Oregon's latest attempt to mandate insurance coverage for fertility treatments has failed for the fifth time since 2021, with HB 4155 dying in the budget committee before reaching a floor vote. The bill, led by Republican House Minority Leader Lucetta Elmer, would have required health insurers to cover fertility diagnosis and treatment including IVF. Despite bipartisan sponsorship — notable for a healthcare mandate bill — the legislation could not overcome fiscal concerns about premium impacts and the committee's reluctance to add new insurance mandates during a period of already rising healthcare costs.

Fertility coverage mandates have been enacted in 21 states plus Washington, D.C., but Oregon's repeated failures highlight the political difficulty of expanding insurance mandates even in a solidly blue state. The cost argument — that mandating IVF coverage increases premiums for all enrollees — has proven persistent despite actuarial analyses suggesting modest per-member-per-month impacts (typically $2-5 PMPM for comprehensive fertility benefits). Oregon's unique dynamic is that its individual market is particularly price-sensitive, with many enrollees receiving ACA subsidies that insulate them from premium increases while the cost falls on the state through increased subsidy outlays. The budget committee's resistance reflects fiscal caution rather than ideological opposition.

For Oregon's healthcare providers and insurers, HB 4155's failure maintains the status quo where fertility treatment remains largely out-of-pocket. A single IVF cycle costs $15,000-$25,000, and many patients require multiple cycles, creating a significant access barrier tied directly to income. The bill's repeated failure also illustrates a broader dynamic in healthcare mandates: each new required benefit increases the baseline cost of insurance, creating cumulative resistance even when individual mandates have modest actuarial impact. For dental providers, this dynamic is directly relevant — advocates for adult dental benefit mandates in states without them face the same fiscal arguments about premium impacts.

Watch for whether the bill returns in Oregon's 2027 legislative session under new sponsorship or a modified approach. Potential strategies include phased implementation, employer-size thresholds (mandating coverage only for large group plans initially), or linking fertility coverage to broader reproductive health legislation that might attract different coalition support. The bipartisan nature of the sponsorship — Republican leadership on a mandate bill — is unusual and suggests the issue has personal resonance across party lines. Also monitor whether Oregon's insurance marketplace premiums for 2027 create a more or less favorable environment for coverage mandate discussions.